Thyroglobulin detection kit and preparation method and detection method thereof

Through trypsinase enzymatic and FR14-specific antibody-coupled Tosyl magnetic bead technology, combined with liquid chromatography tandem mass spectrometry detection, the problem of TgAb interference in thyroglobulin detection is solved, the detection accuracy and sensitivity are improved, and the lower limit of quantification is reduced. Meets higher testing needs.

CN118624917BActive Publication Date: 2024-11-05HANGZHOU BAICHEN MEDICAL INSTR CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411082383.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-08-08
Publication Date
2024-11-05
Estimated Expiration
2044-08-08

AI Technical Summary

Technical Problem

The existing thyroglobulin detection methods are susceptible to interference from serum thyroglobulin antibodies (TgAbs), resulting in low or high detection results, especially in low concentration samples, and the lower limit of quantification is not enough to meet the high-demand detection. need.

Method used

Tg protein was used to enzymatically dissolve Tg protein, combined with FR14-specific antibody-coupled Tosyl magnetic bead technology for enrichment and purification, and the characteristic peptides were detected by liquid chromatography tandem mass spectrometry (LC-MS/MS), reducing the interference of TgAb and improving the Detection accuracy and reduce the lower limit of quantification.

Benefits of technology

It effectively avoids interference with TgAb on the detection results, improves the accuracy and sensitivity of thyroglobulin detection, reduces the lower limit of quantification, and meets higher detection needs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118624917B_ABST
    Figure CN118624917B_ABST
Patent Text Reader

Abstract

The present invention relates to a thyroglobulin detection kit and a preparation method and detection method thereof. The kit includes a calibrator, a quality control product, an internal standard stock solution, a protein precipitant, an enzymatic reaction solution, an enzymatic hydrolysis solution, an internal standard diluent, a protein enrichment solution, a leaching solution, a protein eluent and a mobile phase stock solution, wherein the protein enrichment solution includes FR14 specific antibody coupled to Tosyl magnetic beads. The present invention uses trypsin to enzymatically hydrolyze Tg protein, and antibody coupled to Tosyl magnetic beads to enrich and purify characteristic peptide segments of Tg protein, thereby avoiding interference caused by TgAb in the direct detection of Tg and improving the accuracy of Tg detection; in addition, a lower quantitative limit is established to meet higher use requirements.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a kit and a detection method thereof, in particular to a thyroglobulin detection kit and a preparation method and a detection method thereof. Background Art

[0002] Thyroglobulin (Tg) is a macromolecular glycoprotein complex usually secreted by normal thyroid follicular epithelial cells. It is a homodimer with a relative molecular mass of 660kDa. Thyroglobulin in the human body is composed of 2767 amino acid residues. It is not only a key precursor for the biosynthesis of thyroid hormones, but also can store thyroid hormones in the gland to meet the needs of the body. Tg is produced by thyroid follicular epithelial cells. Each Tg has 2 thyroxine (T4) and 0.5 triiodothyronine (T3) molecules, which are stored in the thyroid follicular cavity in the form of colloid. Under normal circumstances, Tg circulates in follicular cells and follicular cavities and generally does not enter the blood. Proteolytic enzymes hydrolyze T4 and T3 on the surface of Tg and release them into the blood, while trace amounts are also released into the blood. Thyroid damage caused by inflammation, benign and malignant tumors, surgical trauma, etc. can cause Tg to enter the blood.

[0003] At present, the methods used to detect Tg include radioimmunoassay (RIA), immunoradiometric assay (IRMA) and chemiluminescent immunoassay (CLIA). When measuring Tg by immunoradiometric assay, thyroglobulin antibodies (TgAb) in serum produce competitive inhibition with labeled antibodies, resulting in low test results and false negatives. However, immunoradiometric assay can resist the interference of some TgAb, and the measured Tg value is high, causing false positives. Chemiluminescent immunoassay is one of the mainstream methods for detecting Tg, but the method itself has major defects. Different detection methods can cause TgAb to have different effects on Tg, causing Tg to increase or decrease. When serum Tg is at a low concentration (less than 5ng / mL), the interference is particularly obvious, and when serum TgAb is positive, the difference in Tg detection will be greater.

[0004] Chinese patent CN 108444988 A discloses a thyroglobulin luminescence detection kit, and Chinese patent CN116298313 A discloses a thyroglobulin determination kit and its preparation method, both of which use biotin-labeled antibody-coated magnetic beads to enrich Tg in the sample, and then detect and analyze it through a chemiluminescent immunoassay. The methods disclosed in these two patents show that the specificity experimental results of the kit show that there is no cross-reaction in the detection of high-concentration thyroid-stimulating hormone, follicle-stimulating hormone, triiodothyronine and tetraiodothyronine samples, and it has high specificity. However, the detection of Tg is most susceptible to interference from TgAb, indicating that the Tg detection of the above two patent methods is susceptible to interference from TgAb and has major defects in application. Chinese patent CN114264742A discloses a method for rapid detection of thyroglobulin concentration in plasma, which uses trypsin enzymatic hydrolysis, C18 small column impurity removal, antibody-coupled microparticle magnetic beads enrichment, and finally ultra-high performance liquid chromatography tandem mass spectrometry to determine the concentration of Tg in serum. However, the enzymatic hydrolysis method used in this patent is a dilution enzymatic hydrolysis method, in which plasma is reduced, alkylated and enzymatically hydrolyzed. The whole process uses reagents such as 8 mol / L urea, 2 mol / L thiourea, 100 mmol / L bicarbonate, 10 mmol / L dithiothreitol and 20 mmol / L iodoacetamide, which will inhibit the activity of trypsin, making the enzymatic hydrolysis insufficient, and the product after enzymatic hydrolysis is extremely complex, which seriously affects the enrichment and detection of the target polypeptide; and then it is desalted through a Waters sepakC18 column. This process will lead to the loss of the target peptide segment, limiting the detection of low-concentration samples, and this method has not been verified by matrix effect experiments; the detection limit of the above patent is relatively high, at 5 ng / mL, and cannot meet the use requirements. Summary of the invention

[0005] In view of the problems existing in the prior art, the present invention provides a thyroglobulin detection kit and a detection method thereof. The present invention uses trypsin to hydrolyze Tg protein and antibody-coupled tosyl (Tosyl) magnetic beads to enrich and purify characteristic peptide segments of Tg protein, thereby avoiding the interference caused by TgAb in the direct detection of Tg and improving the accuracy of Tg detection. In addition, a lower quantitative limit is established to meet higher usage requirements.

[0006] In order to achieve the above-mentioned invention object, the technical solution adopted by the present invention is:

[0007] A thyroglobulin detection kit, the kit comprising a calibrator, a quality control product, an internal standard stock solution, a protein precipitant, an enzymatic reaction solution, a proteolytic solution, an internal standard diluent, a protein enrichment solution, a washing solution, a protein eluent and a mobile phase stock solution, the protein enrichment solution comprising a FR14-specific antibody coupled to Tosyl magnetic beads, and the protein enrichment solution is prepared by the following method:

[0008] (1) Preparation of coupling reagents:

[0009] Coupling buffer A: 0.02-1.2 mol / L borate buffer, pH 9.0-9.5; coupling buffer B: buffer A containing 2.0-4.0 mol / L ammonium sulfate, pH 9.0-9.5; coupling blocking or preservation solution: 30-80 mmol / L tris(hydroxymethyl)aminomethane, 0.6-1.5% bovine serum albumin and 0.05-0.15% Tween-20, pH 7.0-7.5;

[0010] (2) Preparation of protein enrichment solution:

[0011] Prepare an ultrafiltration centrifuge tube, add water, and centrifuge; add coupling buffer A for replacement; take the antibody and add it to the prepared ultrafiltration centrifuge tube, centrifuge, add coupling buffer A again, centrifuge, and repeat several times; transfer the centrifuged antibody to a microcentrifuge tube (eppendorf tube, EP tube), vortex, and measure the antibody concentration; use a vortex mixer to fully mix and suspend the Tosyl magnetic beads, centrifuge, and remove the supernatant; add coupling buffer A, vortex to disperse the magnetic beads, and remove the supernatant; repeat more than once, add the antibody, and use Replenish coupling buffer A, vortex to disperse the magnetic beads; add coupling buffer B and vortex to mix; keep the magnetic beads rotating and mixing, react at 30-45°C for 12-20 hours, and remove the supernatant; add blocking solution, vortex to disperse the magnetic beads, keep the magnetic beads rotating and mixing, react at 30-45°C for 6-16 hours, and remove the supernatant; add preservation solution, vortex to disperse the magnetic beads, remove the supernatant, and repeat this step more than once to obtain magnetic bead preservation solution; add magnetic bead preservation solution, vortex to mix, and obtain protein enrichment solution.

[0012] Preferably, the calibrator comprises several concentrations of thyroglobulin, and the concentration of the calibrator is 0.1-60 ng / mL; the quality control comprises more than two concentrations of thyroglobulin, and the concentration of the quality control is 1.0-50 ng / mL; the internal standard stock solution comprises FR14-specific antibody, and the amino acid sequence of FR14-specific antibody is: phenylalanine-serine-proline-aspartic acid-aspartic acid-serine-alanine-glycine-alanine-serine-alanine-leucine-leucine-arginine (Phe-Ser-Pro-Asp-Asp-Ser-Ala-Gly-Ala- Ser-Ala-Leu-Leu-Arg), and the single-letter abbreviation sequence is: FSPDDSAGASALLR (abbreviated as FR14); the protein precipitant is an organic reagent, including methanol, ethanol, acetone, and isopropanol; the enzymatic reaction solution includes an ammonium bicarbonate solution with a concentration of 20 to 500 mmol / L; the protease hydrolysis solution includes trypsin with a concentration of 0.06 to 1.25 μg / μL; the internal standard dilution solution includes a methanol aqueous solution with a volume fraction of 40 to 60%; the protein enrichment solution includes 0.05 to 0.35 mg / mL of FR14-specific antibody coupled to Tosyl magnetic beads, wherein the FR14-specific antibody is a monoclonal antibody or a polyclonal antibody; the particle size of the Tosyl magnetic beads is 0.5 to 5 μm; the eluent includes a phosphate buffer solution (PBS buffer) with a pH of 6.8 to 7.5; the protein eluent includes an acid solution and amino acid, wherein the acid solution is formic acid, acetic acid or trifluoroacetic acid with a volume fraction of 0.5 to 5%; the amino acid is glycine, phenylalanine, methionine or lysine with a concentration of 80 to 120 mmol / L; mobile phase stock solution includes formic acid in water.

[0013] The present invention also provides a method for preparing the above-mentioned thyroglobulin detection kit, comprising the following steps:

[0014] (i) Prepare calibrators, quality control products, internal standard stock solution, protein precipitant, enzymatic reaction solution, protein hydrolyzate solution, internal standard diluent, protein enrichment solution, eluent, protein elution solution and mobile phase stock solution;

[0015] (ii) The above-mentioned calibrators, quality controls, internal standard stock solution, protein precipitant, enzymatic reaction solution, protein hydrolyzate solution, internal standard diluent, protein enrichment solution, eluent, protein elution solution and mobile phase stock solution are loaded into the kit and stored at 2-8°C.

[0016] As a preferred method, the calibration products and quality control products are prepared by using 5% bovine serum albumin-phosphate buffer at different concentrations;

[0017] Preparation of internal standard stock solution: Take thyroglobulin internal standard stock solution and add it to bovine serum albumin-phosphate buffer to prepare 7-12 ng / mL internal standard stock solution, and store it at 2-8°C after aliquoting;

[0018] Preparation of protease hydrolysate: Dissolve trypsin crystals in hydrochloric acid to prepare 0.06-1.25 μg / μL protease hydrolysate, and store at 2-8°C after aliquoting;

[0019] Preparation of enzymatic reaction solution: weigh ammonium bicarbonate, add water, sonicate, dilute to 1000mL with ultrapure water, prepare 80-120mmol / L ammonium bicarbonate, and store at 2-8℃ after aliquoting;

[0020] Preparation of internal standard diluent: Take water and methanol separately, vortex mix, and store at 2-8℃;

[0021] Preparation of eluent: weigh NaCl, KCl, KH2PO4 and K2HPO4 and dissolve them in ultrapure water, add HCl to adjust the pH value to 6.8-7.5, add ultrapure water to make up to 1L, add preservative ProClin 300, and store at 2-8°C after aliquoting;

[0022] Preparation of mobile phase stock solution: Add formic acid to ultrapure water, mix well, and store at 2-8°C after aliquoting.

[0023] In addition, the present invention also provides a non-diagnostic detection method of the above thyroglobulin detection kit, comprising the following steps:

[0024] (I) Preparation of reagents;

[0025] (II) Precipitation and enzymatic hydrolysis: add protein precipitant to the sample, mix, centrifuge, and discard the supernatant; add protein precipitant again, sonicate for 1-5 min at a frequency of 20-50 kHz, remove the sample and mix, centrifuge, and discard the supernatant; add enzymatic hydrolysis reaction solution, sonicate for 3-7 min at a frequency of 20-50 kHz, remove the sample and mix, add protein hydrolysis solution, and perform enzymatic hydrolysis overnight at a constant temperature with shaking;

[0026] (III) Antibody enrichment: After overnight enzymatic hydrolysis, take out the sample to be tested, add internal standard working solution and protein enrichment solution, and shake at a constant temperature;

[0027] (IV) Sample washing and elution: Place the centrifuge tube on a magnetic rack, discard the supernatant, add the eluent and shake to wash, repeat this step of washing; add pure water, let it stand on the magnetic rack, discard the supernatant; add the eluent, shake to elute, place the centrifuge tube on a magnetic rack, and take the supernatant for detection in a mass spectrometer.

[0028] Preferably, step (I) is specifically:

[0029] (a) Prepare 8 standards of different concentrations and 2 quality control products of different concentrations, let stand at room temperature for more than 10 min, vortex mix for 1 min, and set aside; the concentration of the calibrator is 0.2-50 ng / mL, and the concentration of the quality control product is 1.5-30 ng / mL;

[0030] (b) Prepare the internal standard working solution: let the internal standard stock solution stand at room temperature for more than 10 min, dilute it 50 times with the internal standard diluent to prepare the internal standard working solution, and set aside;

[0031] (c) Prepare the mobile phase: dilute the mobile phase stock solution 100-fold with water or acetonitrile to prepare aqueous phase A or organic phase B. Ultrasonicate for 10 min and set aside.

[0032] Preferably, step (II) is as follows: 200 μL of sample is placed in a clean 2.0 mL microcentrifuge tube (EP tube), 1 mL of protein precipitant is added, vortexed for 2 min, centrifuged at 4°C 10000 rpm / min for 3 min, and the supernatant is discarded; 1 mL of protein precipitant is added again, the sample is placed in an ultrasonic cleaner for ultrasonication for 3 min at a frequency of 20 to 50 kHz, the sample is taken out and vortexed for 3 min, centrifuged at 4°C 10000 rpm for 3 min, and the supernatant is discarded; 0.65 mL of enzymatic reaction solution is added, the sample is placed in an ultrasonic cleaner for ultrasonication for 5 min at a frequency of 20 to 50 kHz, the sample is taken out and vortexed for 1 min, 50 μg of protease hydrolysate is added, and enzymolysis is carried out at 37°C 1000 rpm / min with constant temperature shaking overnight.

[0033] Preferably, step (III) is as follows: after overnight enzymatic hydrolysis, the sample to be tested is taken out, 30 μL of internal standard working solution and 150 μL of protein enrichment solution are added, and the mixture is shaken at a constant temperature of 37° C. and 1000 rpm / min for 0.5 h.

[0034] Preferably, step (IV) is as follows: placing the centrifuge tube on a magnetic stand for 1 to 2 minutes, discarding the supernatant; adding 1 mL of eluent and shaking for 2 minutes, placing the centrifuge tube on a magnetic stand for 1 to 2 minutes, discarding the supernatant, and repeating the above steps for washing once; adding 1 mL of pure water, standing on the magnetic stand for 1 to 2 minutes, and discarding the supernatant; adding 100 μL of elution solution, shaking for 2 minutes, placing the centrifuge tube on a magnetic stand for 1 to 2 minutes, taking 100 μL of the supernatant into a 96-well plate, and placing it in a mass spectrometer for detection.

[0035] Preferably, the chromatographic conditions in step (IV) are:

[0036] Chromatographic column: A Sepax Bio C4 reverse phase liquid chromatography column is used, and an online filter is provided in front of the column;

[0037] Flow rate: 0.1 mL / min; column temperature: 45°C; injection: 30 μL;

[0038] Mass spectrometry parameters

[0039] The ion source was an electrospray ionization source; the capillary voltage was 1.5 kV; the desolvation temperature was 600 °C; the desolvation gas flow rate was 800 L•h -1 ; Cone hole backflush gas flow rate 150L•h -1 ;

[0040] The scanning mode adopted multiple reaction monitoring; the dwell time was 160ms; the cone voltage was 46V; and the collision voltage was 20V.

[0041] Liquid chromatography tandem mass spectrometry (LC-MS / MS) analysis method hydrolyzes Tg into multiple small polypeptide molecules by trypsin, enriches the specific peptide segments of Tg protein by the specificity of antigen-antibody binding, and then detects the specific small polypeptide molecules by LC-MS / MS, thereby reducing the interference of TgAb and greatly improving the efficiency and accuracy of Tg detection. Therefore, in order to avoid the Tg value being affected in the case of TgAb being positive, causing the result to be too high or too low, thereby losing its application value, the present invention has created a method for detecting serum Tg concentration by liquid chromatography tandem mass spectrometry.

[0042] The beneficial effects of the present invention are:

[0043] (1) The present invention firstly hydrolyzes Tg in the sample by trypsin, and then selectively couples toluenesulfonyl (Tosyl) magnetic beads with Tg characteristic peptide FR14 antibody to prepare antibody magnetic beads with strong specificity for enrichment, and simultaneously adds structurally stable FR14 isotope internal standard, thereby fundamentally avoiding the interference of TgAb on the sample, improving the accuracy of detection, and reducing the quantitative lower limit of detection.

[0044] (2) The amino acid sequence of the Tg characteristic peptide selected by the present invention is: phenylalanine-serine-proline-aspartic acid-aspartic acid-serine-alanine-glycine-alanine-serine-alanine-leucine-leucine-arginine. The antibody of this structure has strong specificity and has no reaction to antigens similar to its target antigen. Secondly, the antibody has high affinity and strong binding force with the target antigen. The present invention compares the coupling effects of different antibody magnetic beads and selects Tosyl magnetic beads, which are directly covalently coupled with the amino or thiol groups of the antibody under mild alkaline conditions to form a stable imine structure that is not easily degraded. At the same time, the present invention compares different coupling systems, namely the boric acid system and the carbonic acid system, to maintain the antibody activity to the greatest extent, further improving the enrichment effect of the antibody magnetic beads.

[0045] (3) The present invention selects organic reagents to precipitate serum samples and then performs enzymatic hydrolysis. By using organic reagents as precipitants, many interfering substances such as polypeptides, small molecules, pigments, phospholipids, polysaccharides, etc. in the serum are discarded, and only large molecular proteins are retained. Compared with the direct enzymatic hydrolysis method after serum dilution, the matrix effect is reduced, and the detection accuracy is improved to a certain extent. It can also detect lipemia and chylosing blood samples.

[0046] (4) The present invention enriches the characteristic peptide segments of Tg, separates them by liquid chromatography, and then detects the parent ions and daughter ions by multiple reaction monitoring (MRM) scanning mode. This method has the advantages of high sensitivity and high specificity, thereby improving the accuracy of Tg and reducing the quantitative limit of Tg. BRIEF DESCRIPTION OF THE DRAWINGS

[0047] Figure 1 This is the chromatogram of the 0.5 ng / mL Tg sample treated by dilution enzymatic hydrolysis;

[0048] Figure 2 This is the chromatogram of the 0.5 ng / mL Tg sample treated by precipitation enzymatic hydrolysis;

[0049] Figure 3 is the Tg calibration curve diagram;

[0050] Figure 4 This is a first-order fitting regression equation and a scatter plot. DETAILED DESCRIPTION

[0051] The technical scheme of the present invention is further specifically described below through examples, which are provided for the purpose of explaining the present invention, not for limiting the present invention. Based on the examples in this application, all other examples obtained by ordinary technicians in this field without creative work are within the scope of protection of this application.

[0052] The experimental methods described in the examples are conventional methods unless otherwise specified; the reagents and materials described are commercially available unless otherwise specified.

[0053] Experimental methods

[0054] 1. Kit Preparation

[0055] 1. Kit components are shown in Table 1:

[0056] Table 1 Components of Thyroglobulin Detection Kit

[0057]

[0058] 2. Preparation of each component of the kit

[0059] (1) Preparation of coupling reagents: Coupling buffer A: 0.1 mol / L borate buffer, pH 9.0-9.5; Coupling buffer B: buffer A containing 3.0 mol / L ammonium sulfate, pH 9.0-9.5; Coupling blocking / preservation solution: 50 mmol / L tris(hydroxymethyl)aminomethane (Tris) + 1.0% bovine serum albumin (BSA) + 0.1% Tween-20, pH 7.0-7.5.

[0060] (2) Preparation of protein enrichment solution: prepare ultrafiltration centrifuge tubes (Amicon Ultra-0.5 centrifugal filter device, 10k, ultrafiltration centrifuge tubes), add 400 μL of water, and centrifuge at 12000g for 10 min; add 400 μL of coupling buffer A to replace twice, and centrifuge at 12000g for 10 min each time; take FR14 specific antibody and add it to the prepared ultrafiltration centrifuge tube, centrifuge at 12000g for 10 min, add 400 μL of coupling buffer A, centrifuge at 12000g for 10 min, and repeat 3 times; transfer the centrifuged antibody to a 2mL microcentrifuge tube (EP tube), vortex, and measure the antibody concentration; use a vortex mixer to thoroughly mix and suspend Tosyl magnetic beads (Tosyl magnetic beads have a particle size of 0.5-5μm), and take 10 mg into the centrifuge tube; place the centrifuge tube on a magnetic rack for 1-2 min, remove the supernatant; add 1.0 mL of coupling buffer A, vortex to disperse the magnetic beads, and remove the supernatant; repeat twice; add 200-250μg antibody, add coupling buffer A to a total volume of 0.6mL, and vortex to disperse the magnetic beads; add 0.4 mL of coupling buffer B, vortex to mix; keep the magnetic beads rotating and mixing, react at 37℃ for 16 hours, and remove the supernatant; add 1.0mL of blocking solution, vortex to disperse the magnetic beads, keep the magnetic beads rotating and mixing, react at 37℃ for 6h~16h, and remove the supernatant; add 1.0mL of preservation solution, vortex to disperse the magnetic beads, remove the supernatant, and repeat this step twice; add 1.0mL of magnetic bead preservation solution, vortex to mix, and obtain a magnetic bead suspension with a concentration of 10mg / mL and a protein enrichment solution with an antibody concentration of 0.2mg / mL, which are stored at 2-8℃.

[0061] (3) Calibrators and quality controls: Prepare calibrators and quality controls with 5% bovine serum albumin-phosphate (BSA-PBS) solution at the concentrations shown in Table 2 (unit: ng / mL). Package 250 μL per tube and store at 2-8°C.

[0062] Table 2 Concentrations of thyroglobulin calibrators and quality control products

[0063]

[0064] (4) Internal standard stock solution: Take the thyroglobulin internal standard stock solution and add it to 5% BSA-PBS to prepare a 10 ng / mL internal standard stock solution. After packaging, store it at 2℃-8℃.

[0065] (5) Protease hydrolysate: Weigh 20 mg of trypsin crystals and dissolve them in 20 mL of 1 mmol / L hydrochloric acid to prepare 1 μg / μL protease hydrolysate. Aliquot and store at 2°C-8°C.

[0066] (6) Enzymatic hydrolysis reaction solution: weigh 7.906 g of ammonium bicarbonate, add 980 mL of water, ultrasonicate for 5 min, dilute to 1000 mL with ultrapure water to prepare 100 mmol / L ammonium bicarbonate, and store at 2°C-8°C after aliquoting.

[0067] (7) Internal standard diluent: Take 10 mL of water and 10 mL of methanol respectively, vortex mix for 3 min, and store at 2℃-8℃.

[0068] (8) Eluent: Weigh 7.9 g NaCl, 0.2 g KCl, 0.24 g KH2PO4 and 1.8 g K2HPO4 and dissolve them in 800 mL ultrapure water. Add HCl to adjust the pH to 7.2. Add ultrapure water to make up to 1 L. Add 200 μL ProClin 300 and store at 2°C-8°C after aliquoting.

[0069] (9) Eluent: Weigh 3.75 g of glycine, add 400 mL of ultrapure water, add 10 mL of formic acid, sonicate for 5 min, make up to 500 mL with ultrapure water, and store at 2°C-8°C after aliquoting.

[0070] (10) Mobile phase stock solution: The composition is 10% formic acid and 90% water. Add 10 mL of formic acid to 90 mL of ultrapure water, mix well, and store at 2°C-8°C after aliquoting.

[0071] (11) The above-mentioned calibrators, quality controls, internal standard stock solution, internal standard diluent, protein precipitant, protein hydrolysate, enzymatic hydrolysis reaction solution, protein enrichment solution, eluent, elution solution and mobile phase stock solution are loaded into the kit and stored at 2°C-8°C.

[0072] 2. Detection Method

[0073] 1. Reagent preparation:

[0074] (1) Calibrators (J1, J2, J3, J4, J5, J6, J7, J8) and quality control materials (Z9, Z10): Let stand at room temperature for more than 10 min, vortex mix for 1 min, and set aside.

[0075] (2) Internal standard working solution: Let the internal standard stock solution stand at room temperature for more than 10 min, dilute it 50 times with internal standard diluent to prepare the internal standard working solution, and set aside.

[0076] (3) Mobile phase: The mobile phase stock solution was diluted 100-fold with water or acetonitrile to prepare aqueous phase (A) or organic phase (B), sonicated for 10 min, and set aside.

[0077] 2. Pre-processing steps:

[0078] (1) Precipitation and enzymatic hydrolysis: Accurately pipette 200 μL of sample into a clean 2.0 mL microcentrifuge tube (EP tube), add 1 mL of protein precipitant, vortex mix for 2 min, centrifuge at 4°C 10,000 rpm / min for 3 min, and discard the supernatant; add 1 mL of protein precipitant again, place in an ultrasonic cleaner for 3 min at a frequency of 20-50 kHz, take out the sample, vortex mix for 3 min, centrifuge at 4°C 10,000 rpm for 3 min, and discard the supernatant; add 0.65 mL of enzymatic hydrolysis reaction solution, place in an ultrasonic cleaner for 5 min at a frequency of 20-50 kHz, take out the sample, vortex mix for 1 min, add 50 μg of protein hydrolyzate, and perform enzymatic hydrolysis at 37°C 1,000 rpm / min overnight.

[0079] (2) Antibody enrichment: After overnight enzymatic hydrolysis, remove the sample to be tested, add 30 μL of internal standard working solution, add 150 μL of protein enrichment solution, and shake at 37°C 1000 rpm / min for 0.5 h. Place the centrifuge tube on a magnetic rack for 1-2 min and discard the supernatant. Add 1 mL of eluent and shake for 2 min. Place the centrifuge tube on a magnetic rack for 1-2 min and discard the supernatant. Repeat this step once. Add 1 mL of pure water and let it stand on a magnetic rack for 1-2 min. Discard the supernatant. Add 100 μL of elution solution and shake for 2 min. Place the centrifuge tube on a magnetic rack for 1-2 min. Take 100 μL of the supernatant and transfer it to a 96-well plate, and place it on a mass spectrometer for detection.

[0080] 3. Chromatographic parameters

[0081] (1) Sepax Bio C4 reversed phase liquid chromatography column (2.1*50mm, 3μm) + online filter;

[0082] (2) Mobile phase A: 0.1% formic acid in water; Mobile phase B: 0.1% formic acid in acetonitrile; Flow rate: 0.1 mL / min; Column temperature: 45°C; Injection: 30 μL;

[0083] (3) Liquid chromatography elution gradient is shown in Table 3:

[0084] Table 3 Chromatographic gradient elution program of thyroglobulin

[0085]

[0086] Mass spectrometry parameters

[0087] (1) Ion source: electrospray ion source (ESI), specific parameters are shown in Table 4:

[0088] Table 4 Ion source parameters

[0089]

[0090] (2) Scanning mode: Multiple reaction monitoring (MRM). Specific parameters are shown in Table 5:

[0091] Table 5 Thyroglobulin protein spectrum conditions

[0092]

[0093] 3. Comparison of the coupling effects of specific antibodies with carboxyl magnetic beads and Tosyl magnetic beads

[0094] (1) Preparation of coupling reagents: Magnetic bead buffer: 0.05 mol / L 2-(N-morpholinoline)ethanesulfonic acid buffer (MES buffer) at pH 6.0; Magnetic bead washing solution: 0.05 M MES buffer at pH 6.0 containing 0.05% Tween-20; Magnetic bead coupling agent: 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) at a concentration of 10 mg / mL in 0.05 M MES buffer at pH 6.0; Magnetic bead blocking solution: polymer blocking agent CE510; Washing buffer: 0.05 M MES buffer at pH 6.0 containing 3% bovine serum albumin (BSA) and 0.2% Tween-20; Magnetic bead protective agent: 0.05% Proclin 300.

[0095] (2) Preparation of carboxyl magnetic bead protein enrichment solution: Take 10 mg of carboxyl magnetic beads, wash once with 500 μL of magnetic bead washing solution, and wash twice with 500 μL of magnetic bead buffer solution; take a certain volume of antibody and add it to the ultrafiltration centrifuge tube prepared in advance, and purify the antibody three times with PBS buffer; take 100 μL of magnetic bead coupling agent and add it to the washed magnetic beads, add 900 μL of magnetic bead buffer solution, mix at room temperature for 30 minutes, and discard the supernatant; add 200 μg of purified antibody, add magnetic bead buffer solution to 1 mL, and mix at room temperature for 3 hours; wash the magnetic beads after coupling for 3 hours with 500 μL of magnetic bead buffer solution three times, add 1 mL of magnetic bead blocking solution, and mix at room temperature for 2 hours; wash the blocked antibody magnetic beads three times with washing buffer solution. After washing, add 97% washing buffer solution + 3% magnetic bead protective agent to the antibody magnetic beads and store them at 2℃-8℃.

[0096] Two mixed human serum samples were selected, each with 6 parallels. One sample was processed using the reagents and detection methods provided by the kit, and the other sample was processed using carboxyl magnetic bead protein enrichment solution. The other reagents remained unchanged. The experimental results were recorded and statistically analyzed. The results are shown in Table 6:

[0097] Table 6 Comparison of coupling effects between carboxyl magnetic beads and Tosyl magnetic beads

[0098]

[0099] The results show that the enrichment efficiency and CV of the Tosyl magnetic beads of the present invention are significantly better than those of the carboxyl magnetic beads.

[0100] 4. Comparison of enrichment effects of different coupling systems of Tosyl magnetic beads

[0101] (1) Preparation of coupling reagents: Coupling buffer: pH 9.0-9.5 carbonate buffer; Coupling reaction solution: 3M ammonium sulfate; Coupling stop solution: polymer-based blocking agent CE510; Coupling storage solution: PBS buffer containing 0.5% bovine serum albumin (BSA) and 0.05% proclin 300.

[0102] (2) Preparation of carbonate system protein enrichment solution: Take 0.1mL of 50mg / mL Tosyl magnetic beads and wash them three times with 0.5mL of coupling buffer; take a certain volume of antibody and purify it by ultrafiltration using coupling buffer, and detect the antibody concentration for later use; take 200μg of purified antibody and 500μL of washed magnetic beads, mix them evenly, add 285μL of antibody coupling agent, and rotate the reaction in a 37℃ constant temperature incubator for 16-22h; add 250μL of polymer blocking agent CE510 and terminate the reaction at room temperature for 4-6h; add 1mL of magnetic bead preservation solution and wash it three times, add 1mL of magnetic bead preservation solution to obtain a carbonate system protein enrichment solution with an antibody concentration of 0.2mg / mL, and store it at 4℃.

[0103] Two mixed human serum samples were selected, each with 6 parallels. One sample was processed using the reagents and detection methods provided by the kit, and the other sample was processed using Tosyl magnetic beads carbonate system protein enrichment solution. The other reagents remained unchanged. The experimental results were recorded and statistically analyzed. The results are shown in Table 7:

[0104] Table 7 Comparison of coupling effects between carboxyl magnetic beads and Tosyl magnetic beads

[0105]

[0106] The results show that the enrichment efficiency and CV of the Tosyl magnetic beads of the present invention in the boric acid system are significantly better than those in the carbonate system.

[0107] 5. Precipitation Enzymatic Hydrolysis

[0108] 1. Comparison of pretreatment between precipitation enzymatic hydrolysis and dilution enzymatic hydrolysis

[0109] Dilution enzymatic hydrolysis method: Accurately pipette 200μL of sample, add 400μL of reducing buffer (containing 150mmol / L ammonium bicarbonate and 15mmol / L dithiothreitol), place the sample on a four-dimensional rotator, and rotate at 37℃ for 1 hour. Then take out the sample and add 67μL of 200mmol / L iodoacetamide under light-proof conditions, and rotate on a four-dimensional rotator at room temperature and light-proof conditions for 0.5 hours. Add 45μL of protease hydrolysis solution and enzymatically hydrolyze at 37℃ overnight. Add 30 μL of internal standard working solution and 150 μL of protein enrichment solution in sequence, shake at a constant temperature of 37℃ 1000 rpm / min for 0.5 h, place the centrifuge tube on a magnetic rack for 1~2 min, and discard the supernatant; add 1 mL of eluent and shake for 2 min, place the centrifuge tube on a magnetic rack for 1~2 min, discard the supernatant, repeat this step of washing once; add 1 mL of pure water, let it stand on the magnetic rack for 1~2 min, and discard the supernatant; add 100 μL of elution solution, shake and elute for 2 min, place the centrifuge tube on a magnetic rack for 1~2 min, take 100 μL of the supernatant to a 96-well plate, and place it in a mass spectrometer for detection.

[0110] The results of pretreatment comparison between dilution enzymatic hydrolysis and precipitation enzymatic hydrolysis are as follows Figure 1 , Figure 2 As shown in the figure, it can be seen that the Tg peak area of ​​the sample treated by dilution enzymatic hydrolysis is 368, the signal-to-noise ratio S / N is 39, the Tg peak area of ​​the sample treated by precipitation enzymatic hydrolysis is 758, the signal-to-noise ratio S / N is 55. Comprehensive comparison shows that the enrichment effect of precipitation enzymatic hydrolysis is better than that of dilution enzymatic hydrolysis, and the matrix interference of the sample is less than that of dilution enzymatic hydrolysis.

[0111] 2. Comparison of different protein precipitants

[0112] A mixed human serum sample was selected and divided into 3 parts, each with 6 parallels. One sample used methanol as a protein precipitant, one used ethanol as a protein precipitant, and one used acetonitrile as a protein precipitant. The remaining reagents were processed using the reagents and detection methods provided by the kit. The experimental results were recorded and statistically analyzed. The comparison results of different protein precipitants are shown in Table 8.

[0113] Table 8 Comparison of different protein precipitants

[0114]

[0115] The results show that methanol is better than ethanol and acetonitrile among the three protein precipitants. Therefore, methanol is the preferred protein precipitant in this experiment, and ethanol can also be used.

[0116] 3. Comparison of different ultrasound times, times and frequencies

[0117] A mixed human serum sample was selected and divided into two parts, each with 6 parallels. One part was treated with ultrasound once and the other was treated with ultrasound twice. The other operations remained unchanged. The comparison results of different ultrasound times are shown in Table 9. The experimental results show that the thyroglobulin detection results of ultrasound twice are better than those of ultrasound once.

[0118] Table 9 Comparison of different ultrasound times

[0119]

[0120] For different ultrasonic times, 1 min, 3 min, 5 min, and 7 min were selected for comparative analysis, and for ultrasonic frequencies, 10 kHz, 20 kHz, 30 kHz, 40 kHz, and 50 kHz were selected for comparative analysis. The results are shown in Table 10.

[0121] Table 10

[0122]

[0123] According to the above results, the first ultrasonic time is preferably 3 minutes, and the ultrasonic frequency can be selected from 20kHz to 50kHz; the second ultrasonic time is preferably 5 minutes, and the ultrasonic frequency can be selected from 20kHz to 50kHz.

[0124] 6. Precision

[0125] The sample concentrations at low and high concentration levels were tested respectively, and repeated 3 times each day for 5 consecutive days. The intra-batch and inter-batch precision were calculated. The results of the 5-day precision experiment are shown in Table 11:

[0126] Table 11 5-day precision of thyroglobulin

[0127]

[0128] The 5-day precision experiment showed that the method of the present invention has good intra-batch and inter-batch precision, and both the intra-batch and inter-batch precision meet the requirements.

[0129] VII. Correctness Verification

[0130] Select actual patient serum as the basic sample for the recovery experiment, and mix 200ul of low, medium and high standard samples with 1800ul of basic sample respectively, as shown in Table 12, the low concentration is 5 times the lower limit of the linear range; the medium concentration is the middle concentration of the linear range; the high concentration is 70% of the upper limit of the linear range. Repeat the above "basic sample" and "experimental sample" for 6 parallel determinations, record the experimental results and perform statistical analysis on the spiked recovery of the three concentrations of low, medium and high (low concentration: 5 times the linear low point; medium concentration: half of the linear highest point; high concentration: 70% of the upper limit of the linear range), recovery rate = (detection value - basic sample value) / theoretical value × 100%, requiring 85% < recovery rate < 115%.

[0131] Table 12 Spike recovery preparation table

[0132]

[0133] The accuracy of the spike recovery verification method is shown in Table 13:

[0134] Table 13 Tg accuracy verification results

[0135]

[0136] The results showed that the average recovery rate of thyroglobulin was 96.76%, which met the requirements (requirement: 85% < average recovery rate < 115%).

[0137] 8. Lower limit of quantification

[0138] The lower limit of quantification is the lowest value of the target analyte that can be detected by the LC-MS / MS method under the premise of meeting the laboratory's requirements for accuracy and precision. Three samples with concentrations close to the detection limit were selected for the lower limit of quantification. Each concentration sample was divided into 5 parts for processing. Each sample was repeated 3 times, and 3 batches were measured continuously. The total precision (CV) of each concentration sample and the deviation of its concentration measurement mean from the theoretical concentration were evaluated respectively. The measurement mean of the lowest concentration sample with CV≤20% and bias<15% was taken as the lower limit of quantification of the method.

[0139] The quantitative lower limit results of thyroglobulin Tg are shown in Table 14:

[0140] Table 14 Tg quantitative lower limit results

[0141]

[0142] The results showed that the lower limit of quantification of thyroglobulin was 0.2 ng / mL, indicating that the method of the present invention can still ensure the reliability of the results when detecting low-concentration samples.

[0143] IX. Dilution Reliability

[0144] Collect patient plasma near the upper limit of the linear range (AMR), dilute it 2 and 4 times with water respectively, and require that the recovery rate (diluted test value / theoretical value) is 80% ≤ 120%, and the dilution is judged to have passed the verification.

[0145] The Tg dilution reliability results are shown in Table 15:

[0146] Table 15 Tg dilution reliability results

[0147]

[0148] The results showed that the method of the present invention can ensure the reliability of the results when diluting the sample with high concentration by 4 times.

[0149] 10. Linear Verification

[0150] Calibration curve linearity test

[0151] The Tg calibration curve is shown in Figure 3 The Tg linearity and retention time results are shown in Table 16:

[0152] Table 16 Tg linearity and retention time

[0153]

[0154] The results showed that the Tg calibration curve range was 0.20-50 ng / mL, and the correlation coefficient was 0.9993, which met the requirements (R 2 ≥0.99).

[0155] Refer to the requirements of the health industry standard (WS / T 480-2012) "Guidelines for Linear Evaluation of Clinical Chemistry Equipment", and select samples with 5 concentration levels for linear range verification. Each sample should be repeated 4 times, and all samples should complete pre-treatment and quantitative detection in the fastest time. The obtained data is fitted with a regression equation and a scatter plot is drawn. When the correlation coefficient R2 ≥ 0.95 and the regression coefficient b is within the range of 0.97-1.03, it is qualified within the linear range.

[0156] The linear validation results of thyroglobulin Tg are shown in Table 17. The first-order fitting regression equation and scatter plot are shown in Figure 4 As shown, the linear range verifies the regression equation y=0.9948x+0.1293, R 2 =0.9998:

[0157] Table 17 Tg linearity verification results

[0158]

[0159] A regression statistical analysis was performed on the expected and measured values ​​of thyroglobulin, and the regression coefficient b=0.9948 and R2≥0.9998 were obtained, which met the requirements of the "Guidelines for Linear Evaluation of Clinical Chemistry Equipment", indicating that the linearity of this method meets the verification requirements.

[0160] 11. Matrix Effects

[0161] The experiment selected pure solution of the target analyte, biological matrix sample and a 1:1 mixture of the two, and processed them separately before injection analysis. If the difference between the response value of the 1:1 mixture sample and the mean response value of the biological matrix sample and the pure solution sample is less than a certain proportion (20%), it proves whether the matrix effect exists or does not affect the accurate quantification of the target analyte.

[0162] The matrix effect results of different Tg concentrations (low, medium and high levels). Specifically, the results of the low concentration matrix effect experiment (sample 1-sample 6) are shown in Table 18:

[0163] Table 18

[0164]

[0165] The results of the medium concentration matrix effect experiment (sample 1-sample 6) are shown in Table 19:

[0166] Table 19

[0167]

[0168] The results of the high concentration matrix effect experiment (sample 1-sample 6) are shown in Table 20:

[0169] Table 20

[0170]

[0171] The matrix effect of thyroglobulin was investigated and analyzed at different concentrations. The results showed that the deviations at low, medium and high levels were all less than 10%, indicating that the method was less affected by interference and did not affect the quantification of the target compound.

[0172] The present invention prepares antibody-coupled magnetic microparticles, Tg calibrators and quality control products and corresponding supporting reagents to form a Tg detection kit, uses an organic reagent to extract impurities and precipitated proteins, discards the extract, uses trypsin to hydrolyze the precipitated proteins to generate polypeptides, enriches specific small-molecule polypeptides by antibody-coupled magnetic microparticles, removes impurities and collects the enriched specific small-molecule polypeptides, and then uses a triple quadrupole mass spectrometer Waters TQS for detection. The reliability and stability of the method are verified through a series of experiments.

[0173] Finally, it should be noted that the above are only some specific embodiments of the present invention. Obviously, the present invention is not limited to the above embodiments, and there are many variations. All variations that can be directly derived or associated with the content disclosed by ordinary technicians in this field should be considered as the protection scope of the present invention.

Claims

1. A thyroglobulin detection kit, characterized in that: The kit includes a calibrator, a quality control product, an internal standard stock solution, a protein precipitant, an enzymatic reaction solution, a proteolytic solution, an internal standard diluent, a protein enrichment solution, a washing solution, a protein eluent and a mobile phase stock solution, wherein the protein enrichment solution includes a FR14-specific antibody coupled to a tosyl magnetic bead, and the protein enrichment solution is prepared by the following method: (1) Preparation of coupling reagents: Coupling buffer A: 0.02-1.2 mol / L borate buffer, pH 9.0-9.5; Coupling buffer B: Buffer A containing 2.0-4.0 mol / L ammonium sulfate, pH 9.0-9.5; Coupling blocking or preservation solution: 30-80 mmol / L tris(hydroxymethyl)aminomethane, 0.6-1.5% bovine serum albumin and 0.05-0.15% Tween-20, pH 7.0-7.5; (2) Preparation of protein enrichment solution: Prepare an ultrafiltration centrifuge tube, add water, and centrifuge; add coupling buffer A for replacement; take the antibody and add it to the prepared ultrafiltration centrifuge tube, centrifuge, add coupling buffer A again, centrifuge, and repeat several times; transfer the centrifuged antibody to a microcentrifuge tube, vortex, and determine the antibody concentration; use a vortex mixer to fully mix and suspend the tosyl magnetic beads, centrifuge, and remove the supernatant; add coupling buffer A, vortex to disperse the magnetic beads, and remove the supernatant; repeat more than once, add the antibody, supplement with coupling buffer A, vortex to disperse the magnetic beads; add coupling buffer B, vortex to mix; keep the magnetic beads rotating and mixing, react at 30-45°C for 12-20 hours, and then remove the supernatant; add blocking solution, vortex to disperse the magnetic beads, keep the magnetic beads rotating and mixing, react at 30-45°C for 6-16 hours, and remove the supernatant; add preservation solution, vortex to disperse the magnetic beads, remove the supernatant, and repeat this step more than once to obtain the magnetic bead preservation solution; Add magnetic bead preservation solution and vortex to mix well to obtain protein enrichment solution; The calibrator includes several concentrations of thyroglobulin, and the concentration of the calibrator is 0.1 to 60 ng / mL; The quality control product includes more than two concentrations of thyroglobulin, and the concentration of the quality control product is 1.0 to 50 ng / mL; The internal standard stock solution includes a FR14-specific antibody, and the amino acid sequence of the FR14-specific antibody is: phenylalanine-serine-proline-aspartic acid-aspartic acid-serine-alanine-glycine-alanine-serine-alanine-leucine-leucine-arginine; The protein precipitant is an organic reagent, including methanol, ethanol, acetone, and isopropanol; The enzymatic hydrolysis reaction solution includes an ammonium bicarbonate solution with a concentration of 20 to 500 mmol / L; The protease hydrolysate includes trypsin at a concentration of 0.06 to 1.25 μg / μL; The internal standard diluent comprises a methanol aqueous solution with a volume fraction of 40 to 60%; The protein enrichment solution comprises 0.05-0.35 mg / mL of FR14-specific antibody coupled tosyl magnetic beads, wherein the FR14-specific antibody is a monoclonal antibody or a polyclonal antibody; the particle size of the tosyl magnetic beads is 0.5-5 μm; The eluent comprises a phosphate buffer solution, pH 6.8-7.5; The protein eluent includes an acid solution and an amino acid, wherein the acid solution is formic acid, acetic acid or trifluoroacetic acid, and the volume fraction is 0.5-5%; the amino acid is glycine, phenylalanine, methionine or lysine, and the concentration is 80-120 mmol / L; The mobile phase stock solution consisted of formic acid in water.

2. A method for preparing the thyroglobulin detection kit according to claim 1, characterized in that The steps include: (i) Prepare calibrators, quality control products, internal standard stock solution, protein precipitant, enzymatic reaction solution, protein hydrolyzate solution, internal standard diluent, protein enrichment solution, eluent, protein elution solution and mobile phase stock solution; (ii) The above-mentioned calibrators, quality controls, internal standard stock solution, protein precipitant, enzymatic reaction solution, protein hydrolyzate solution, internal standard diluent, protein enrichment solution, eluent, protein elution solution and mobile phase stock solution are loaded into the kit and stored at 2-8°C.

3. The method for preparing the thyroglobulin detection kit according to claim 2, characterized in that Preparation of calibrators and quality control products: Use 5% bovine serum albumin-phosphate buffer to prepare calibrators and quality control products at different concentrations; Preparation of internal standard stock solution: Take thyroglobulin internal standard stock solution and add it to bovine serum albumin-phosphate buffer to prepare 7-12 ng / mL internal standard stock solution, and store it at 2-8°C after aliquoting; Preparation of protease hydrolysate: Dissolve trypsin crystals in hydrochloric acid to prepare 0.06-1.25 μg / μL protease hydrolysate, and store at 2-8°C after aliquoting; Preparation of enzymatic reaction solution: weigh ammonium bicarbonate, add water, sonicate, dilute to 1000mL with ultrapure water, prepare 80-120mmol / L ammonium bicarbonate, and store at 2-8℃ after aliquoting; Preparation of internal standard diluent: Take water and methanol separately, vortex mix, and store at 2-8℃; Preparation of eluent: weigh NaCl, KCl, KH2PO4 and K2HPO4 and dissolve them in ultrapure water, add HCl to adjust the pH value to 6.8-7.5, add ultrapure water to make up to 1L, add preservative Prolec 300, and store at 2-8℃ after aliquoting; Preparation of mobile phase stock solution: Add formic acid to ultrapure water, mix well, and store at 2-8°C after aliquoting.

4. A non-diagnostic detection method of the thyroglobulin detection kit according to claim 1, characterized in that The steps include: (I) Preparation of reagents; (II) Precipitation and enzymatic hydrolysis: add protein precipitant to the sample, mix, centrifuge, and discard the supernatant; add protein precipitant again, sonicate for 1-5 min at a frequency of 20-50 kHz, remove the sample and mix, centrifuge, and discard the supernatant; add enzymatic hydrolysis reaction solution, sonicate for 3-7 min at a frequency of 20-50 kHz, remove the sample and mix, add protein hydrolysis solution, and perform enzymatic hydrolysis overnight at a constant temperature with shaking; (III) Antibody enrichment: After overnight enzymatic hydrolysis, take out the sample to be tested, add internal standard working solution and protein enrichment solution, and shake at a constant temperature; (IV) Sample washing and elution: Place the centrifuge tube on a magnetic rack, discard the supernatant, add the washing solution and shake and wash, and repeat this step; Add pure water, let it stand on the magnetic rack, discard the supernatant; add the eluent, shake and elute, place the centrifuge tube on the magnetic rack, and take the supernatant for detection in the mass spectrometer.

5. The non-diagnostic detection method of the thyroglobulin detection kit according to claim 4, characterized in that Step (I) is specifically as follows: (a) Prepare 8 standards of different concentrations and 2 quality control products of different concentrations, let stand at room temperature for more than 10 min, vortex mix for 1 min, and set aside; the concentration of the calibrator is 0.2-50 ng / mL, and the concentration of the quality control product is 1.5-30 ng / mL; (b) Prepare the internal standard working solution: let the internal standard stock solution stand at room temperature for more than 10 min, dilute it 50 times with the internal standard diluent to prepare the internal standard working solution, and set aside; (c) Prepare the mobile phase: dilute the mobile phase stock solution 100-fold with water or acetonitrile to prepare aqueous phase A or organic phase B. Ultrasonicate for 10 min and set aside.

6. The non-diagnostic detection method of the thyroglobulin detection kit according to claim 4, characterized in that Step (II) is as follows: 200 μL of sample is taken and placed in a clean 2.0 mL microcentrifuge tube, 1 mL of protein precipitant is added, vortexed for 2 minutes, centrifuged at 4°C 10000 rpm / min for 3 minutes, and the supernatant is discarded; 1 mL of protein precipitant is added again, the tube is placed in an ultrasonic cleaner for ultrasonication for 3 minutes at a frequency of 20 to 50 kHz, the sample is taken out and vortexed for 3 minutes, centrifuged at 4°C 10000 rpm for 3 minutes, and the supernatant is discarded; 0.65 mL of enzymatic reaction solution is added, the tube is placed in an ultrasonic cleaner for ultrasonication for 5 minutes at a frequency of 20 to 50 kHz, the sample is taken out and vortexed for 1 minute, 50 μg of protease hydrolysate is added, and enzymolysis is carried out at 37°C 1000 rpm / min overnight.

7. The non-diagnostic detection method of the thyroglobulin detection kit according to claim 4, characterized in that Step (III) is as follows: after overnight enzymatic hydrolysis, take out the sample to be tested, add 30 μL of internal standard working solution and 150 μL of protein enrichment solution, and shake at a constant temperature of 37°C and 1000 rpm / min for 0.5 h.

8. The non-diagnostic detection method of the thyroglobulin detection kit according to claim 4, characterized in that Step (IV) is as follows: placing the centrifuge tube on the magnetic rack for 1 to 2 minutes, discarding the supernatant; adding 1 mL of eluent and shaking for 2 minutes, placing the centrifuge tube on the magnetic rack for 1 to 2 minutes, discarding the supernatant, and repeating the above steps for washing once; Add 1 mL of pure water, let it stand on the magnetic rack for 1 to 2 min, and discard the supernatant; add 100 μL of elution buffer, shake and elute for 2 min, place the centrifuge tube on the magnetic rack for 1 to 2 min, take 100 μL of the supernatant to a 96-well plate, and place it in a mass spectrometer for detection.

9. The non-diagnostic detection method of the thyroglobulin detection kit according to claim 4, characterized in that Chromatographic conditions in step (IV): Chromatographic column: A Seifen reverse phase liquid chromatography column is used, and an online filter is provided in front of the column; Flow rate: 0.1 mL / min; column temperature: 45 °C; injection: 30 μL; Mass spectrometry parameters The ion source was an electrospray ionization source; the capillary voltage was 1.5 kV; the desolvation temperature was 600 °C; the desolvation gas flow rate was 800 L•h -1 ; Cone hole backflush gas flow rate 150L•h -1 ; The scanning mode adopted multiple reaction monitoring; the dwell time was 160ms; the cone voltage was 46V; and the collision voltage was 20V.